1). Turesson C., O'Fallon WM., Crowson CS., Gabriel SE., Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003. 62:722–7.
Article
2). Helin HJ., Korpela MM., Mustonen JT., Pasternack AI. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum. 1995. 38:242–7.
Article
3). Qarni MU., Kohan DE. Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis. Clin Nephrol. 2000. 54:54–8.
4). Harper L., Cockwell P., Howie AJ., Michael J., Richards NT., Savage CO, et al. Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM. 1997. 90:125–32.
Article
5). Scott DG., Bacon PA., Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 1981. 60:288–97.
6). Genta MS., Genta RM., Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006. 36:88–98.
Article
7). Bosch X., Llena J., Collado A., Font J., Mirapeix E., Ingelmo M, et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri) nuclear antibodies in rheumatoid arthritis. J Rheumatol. 1995. 22:2038–45.
8). Cambridge G., Williams M., Leaker B., Corbett M., Smith CR. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Ann Rheum Dis. 1994. 53:24–9.
Article
9). Mulder AH., Horst G., van Leeuwen MA., Limburg PC., Kallenberg CG. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations. Arthritis Rheum. 1993. 36:1054–60.
Article
10). Mustila A., Korpela M., Mustonen J., Helin H., Huhtala H., Soppi E, et al. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. Arthritis Rheum. 1997. 40:710–7.
Article
11). Goto A., Mukai M., Notoya A., Kohno M. Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report. Mod Rheumatol. 2005. 15:118–22.
Article
12). Palomar R., Castaneda O., Rodrigo E., Ruiz San-Millan JC., Martin Gago J., Morales P, et al. Microscopic polyangiitis in a patient with rheumatoid arthritis. Nefrologia. 2005. 25:438–41.
13). Sugimoto T., Koyama T., Kanasaki K., Morita Y., Yokomaku Y., Deji N, et al. Antineutrophil cytoplasmic antibodies-related necrotising crescentic glomerulonephritis in a patient with rheumatoid arthritis. Nephrology (Carlton). 2006. 11:478.
Article
14). Yorioka N., Taniguchi Y., Amimoto D., Miyata H., Yamakido M., Taguchi T. Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis. Am J Nephrol. 1999. 19:527–9.
Article
15). Langford CA. Treatment of ANCA-associated vasculitis. N Engl J Med. 2003. 349:3–4.
Article